Hamilton Lane Incorporated Class A HLNE 深 沪
等待开盘 10-16 09:30:00 美东时间
120.19
-4.730
-3.79%
华盛通- 最 高127.2076
- 今 开126.9487
- 成交量 51.90万股
- 最 低 119.10
- 昨 收 124.92
- 总市值 49.73亿
- 52周最高 201.66
- 市盈率 静 22.23
- 换手率 0.00%
- 52周最低 114.63
- 委 比 79.76%
- 总股本 4137.47万
- 历史最高 201.66
- 量 比 0.66
- 振 幅 6.49%
- 历史最低 5.60
- 每 手 1
- 风险率 23.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
10-15 18:20
100% Of This Hamilton Lane Insider's Holdings Were Sold
Looking at Hamilton Lane Incorporated's (NASDAQ:HLNE ) insider transactions ove...
10-15 03:05
Why Hamilton Lane's Correction Isn't Over Yet
Adhishthana.com analysis reveals Hamilton Lane's descent leg is still unfolding, suggesting more correction ahead before stability returns.
10-14 22:16
美股大行评级 | NTSK、STUB、WBI获多个机构首予评级；高盛上调雅诗兰黛(EL)评级至"买入"，目标价从76美元升至115美元
今日重点评级关注：花旗：维持Arcus Biosciences"买入"评级，目标价从47美元升至54美元；HC Wainwright & Co.：上调Karyopharm Therapeutics评级至"买入"，目标价15美元
10-14 09:56
The Analyst Verdict: Hamilton Lane In The Eyes Of 5 Experts
In the latest quarter, 5 analysts provided ratings for Hamilton Lane (NASDAQ:HL...
10-14 03:01
Keefe, Bruyette & Woods Upgrades Hamilton Lane to Outperform, Lowers Price Target to $150
Keefe, Bruyette & Woods analyst Kyle Voigt upgrades Hamilton Lane (NASDAQ:HLNE) from Market Perform to Outperform and lowers the price target from $168 to $150.
10-14 00:23
Novata acquires Atlas Metrics to advance sustainability data management
Novata announced the acquisition of Atlas Metrics, a top European sustainability performance and reporting platform. This strategic move has broadened Novata’s global reach and united two complementar...
10-07 21:02
Hamilton Lane Amends Loan Agreement with JPMorgan
Hamilton Lane ( ($HLNE) ) just unveiled an update. On October 1, 2025, Hamilton...
10-07 04:48
美股大行评级 | 潜在涨幅1176.6%！Ascendiant Capital上调Society Pass目标价至18美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从15美元升至18美元；Ascendiant Capital：维持Surgepays"买入"评级，目标价从9美元升至9.5美元
10-06 08:35
Hamilton Lane Launches Global Venture Capital And Growth Evergreen Fund Expanding Its $13B+ Evergreen Platform With $117.8B Supervised Assets
The Fund offers access to innovative private venture and growth investments not available in the public markets
10-01 14:13
